Lepu Medical > News > Exhibition > Invitation to MyLive 2017 !
Invitation to MyLive 2017 !

MYLIVE 2017, Lepu Medical is going to display series of interventional products concentrating in cardiac therapy. Welcome to visit us at booth A7 to get to know more about Lepu products! Lepu Medical do hope that we could have the opportunity to work with you!

About MYLIVE 2017
MYLIVE 2017 is the Interventional Cardiovascular Society of Malaysia (ICSM) annual conference with Live Transmission. This is the 14th MYLIVE and over the last decade it has undergone remarkable growth and significant for cardiovascular fraternity and people in the related field to meet, to discuss and networks with colleagues from the region and abroad to share the best practices and know-how for the betterment of cardiovascular care in the region.

The theme for MYLIVE 2017 is Doing It Right. MYLIVE 2017 will again showcase the best of cardiac and other vascular intervention and how to treat it right. In this two and half days meeting we will have many symposia, case sharing, how to treat sessions addressing each important topics - left main disease, bifurcation, chronic total occlusion, long and small vessel, calcified lesions, STEMI intervention, structural and peripheral intervention, learning to integrate the right techniques and devices for optimal management of our patients. Live Transmission for MYLIVE 2017 will be from National Heart Institute, one of largest interventional center in the region.

About Lepu Medical

Lepu Medical Technology (Beijing) Co., Ltd. was established in 1999. Lepu Medical is specialized in developing, manufacturing and distributing the high-tech medical devices and equipment. Today, Lepu Medical has grown into a global leading group company in the fields of cardiovascular, neurovascular and peripheral vascular interventions, structural heart diseases, surgical cardiology, cardiac rhythm management, anesthesia and intensive care, in vitro diagnostics and general surgery. In 2009, Lepu Medical successfully listed on ChiNext Shenzhen Stock Exchange market (stock code: 300003).

Now Lepu Medical totally has 28 primary subsidiary companies worldwide. There are more than 60 products have received the CE certificates, and 6 products have got the FDA approvals. Lepu Medical has established three overseas subsidiary companies in Netherland, Turkey and India, obtained local registrations in 27 countries, and built the sales and distribution channels in over 80 countries and regions.

Lepu Medical upholds “integrity, quality and scientific innovation” as its spirit, commitments to provide the best quality of products and services to satisfy the needs of healthcare professionals and patients.


SOURCE: Lepu Medical International Sales & Marketing Department
© Copyright  1999-2014  lepumedical.com,  All rights reserved
版权所有    乐普(北京)医疗器械股份有限公司    京ICP备13012321号